nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—EIF4E—forebrain—endogenous depression	0.0561	0.0659	CbGeAlD
Sirolimus—EIF4E—cardiovascular system—endogenous depression	0.0474	0.0558	CbGeAlD
Sirolimus—EIF4E—endocrine gland—endogenous depression	0.0325	0.0382	CbGeAlD
Sirolimus—EIF4E—nervous system—endogenous depression	0.0304	0.0358	CbGeAlD
Sirolimus—EIF4E—central nervous system—endogenous depression	0.0293	0.0345	CbGeAlD
Sirolimus—FGF2—pituitary gland—endogenous depression	0.0256	0.0301	CbGeAlD
Sirolimus—EIF4E—brain—endogenous depression	0.0233	0.0274	CbGeAlD
Sirolimus—FGF2—adrenal gland—endogenous depression	0.0229	0.0269	CbGeAlD
Sirolimus—FGF2—midbrain—endogenous depression	0.0226	0.0266	CbGeAlD
Sirolimus—MTOR—brainstem—endogenous depression	0.0225	0.0264	CbGeAlD
Sirolimus—FGF2—thyroid gland—endogenous depression	0.0221	0.026	CbGeAlD
Sirolimus—MTOR—forebrain—endogenous depression	0.0217	0.0255	CbGeAlD
Sirolimus—FKBP1A—forebrain—endogenous depression	0.0195	0.0229	CbGeAlD
Sirolimus—MTOR—cardiovascular system—endogenous depression	0.0183	0.0216	CbGeAlD
Sirolimus—FKBP1A—adrenal cortex—endogenous depression	0.0181	0.0213	CbGeAlD
Sirolimus—FGF2—cerebellum—endogenous depression	0.0175	0.0205	CbGeAlD
Sirolimus—SLC47A1—brainstem—endogenous depression	0.0174	0.0204	CbGeAlD
Sirolimus—FKBP1A—cardiovascular system—endogenous depression	0.0165	0.0194	CbGeAlD
Sirolimus—MTOR—pituitary gland—endogenous depression	0.0162	0.0191	CbGeAlD
Sirolimus—Temsirolimus—CYP2D6—endogenous depression	0.0158	1	CrCbGaD
Sirolimus—SLC47A1—adrenal cortex—endogenous depression	0.0155	0.0183	CbGeAlD
Sirolimus—FKBP1A—pituitary gland—endogenous depression	0.0146	0.0172	CbGeAlD
Sirolimus—MTOR—adrenal gland—endogenous depression	0.0145	0.0171	CbGeAlD
Sirolimus—FGF2—brain—endogenous depression	0.0142	0.0167	CbGeAlD
Sirolimus—CYP3A7—endocrine gland—endogenous depression	0.014	0.0165	CbGeAlD
Sirolimus—MTOR—thyroid gland—endogenous depression	0.014	0.0165	CbGeAlD
Sirolimus—FKBP1A—adrenal gland—endogenous depression	0.013	0.0153	CbGeAlD
Sirolimus—FKBP1A—midbrain—endogenous depression	0.0129	0.0152	CbGeAlD
Sirolimus—FKBP1A—thyroid gland—endogenous depression	0.0126	0.0148	CbGeAlD
Sirolimus—MTOR—endocrine gland—endogenous depression	0.0126	0.0148	CbGeAlD
Sirolimus—SLC47A1—pituitary gland—endogenous depression	0.0126	0.0148	CbGeAlD
Sirolimus—MTOR—nervous system—endogenous depression	0.0118	0.0138	CbGeAlD
Sirolimus—MTOR—central nervous system—endogenous depression	0.0113	0.0133	CbGeAlD
Sirolimus—FKBP1A—endocrine gland—endogenous depression	0.0113	0.0133	CbGeAlD
Sirolimus—SLC47A1—adrenal gland—endogenous depression	0.0112	0.0132	CbGeAlD
Sirolimus—MTOR—cerebellum—endogenous depression	0.0111	0.013	CbGeAlD
Sirolimus—SLCO1B1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.0109	0.0818	CbGpPWpGaD
Sirolimus—SLC47A1—thyroid gland—endogenous depression	0.0108	0.0127	CbGeAlD
Sirolimus—FKBP1A—nervous system—endogenous depression	0.0106	0.0125	CbGeAlD
Sirolimus—FKBP1A—central nervous system—endogenous depression	0.0102	0.012	CbGeAlD
Sirolimus—FKBP1A—cerebellum—endogenous depression	0.00997	0.0117	CbGeAlD
Sirolimus—SLC47A1—endocrine gland—endogenous depression	0.00973	0.0114	CbGeAlD
Sirolimus—SLCO1B1—endocrine gland—endogenous depression	0.0096	0.0113	CbGeAlD
Sirolimus—SLC47A1—nervous system—endogenous depression	0.0091	0.0107	CbGeAlD
Sirolimus—MTOR—brain—endogenous depression	0.009	0.0106	CbGeAlD
Sirolimus—SLC47A1—central nervous system—endogenous depression	0.00876	0.0103	CbGeAlD
Sirolimus—SLC47A1—cerebellum—endogenous depression	0.00857	0.0101	CbGeAlD
Sirolimus—FKBP1A—brain—endogenous depression	0.0081	0.00952	CbGeAlD
Sirolimus—SLC47A1—brain—endogenous depression	0.00696	0.00818	CbGeAlD
Sirolimus—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.00571	0.0427	CbGpPWpGaD
Sirolimus—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00548	0.0409	CbGpPWpGaD
Sirolimus—CYP3A5—endocrine gland—endogenous depression	0.00493	0.0058	CbGeAlD
Sirolimus—CYP3A7—Xenobiotics—CYP2D6—endogenous depression	0.00483	0.0361	CbGpPWpGaD
Sirolimus—ABCB1—forebrain—endogenous depression	0.00451	0.00531	CbGeAlD
Sirolimus—ABCB1—adrenal cortex—endogenous depression	0.00418	0.00492	CbGeAlD
Sirolimus—ABCB1—cardiovascular system—endogenous depression	0.00382	0.00449	CbGeAlD
Sirolimus—CYP3A4—endocrine gland—endogenous depression	0.0037	0.00435	CbGeAlD
Sirolimus—MTOR—FSH signaling pathway—BDNF—endogenous depression	0.00349	0.0261	CbGpPWpGaD
Sirolimus—CYP3A5—Xenobiotics—CYP2D6—endogenous depression	0.00349	0.0261	CbGpPWpGaD
Sirolimus—CYP3A4—nervous system—endogenous depression	0.00346	0.00407	CbGeAlD
Sirolimus—ABCB1—pituitary gland—endogenous depression	0.00338	0.00397	CbGeAlD
Sirolimus—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00338	0.0252	CbGpPWpGaD
Sirolimus—CYP3A5—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00336	0.0251	CbGpPWpGaD
Sirolimus—CYP3A4—central nervous system—endogenous depression	0.00333	0.00392	CbGeAlD
Sirolimus—ABCB1—adrenal gland—endogenous depression	0.00302	0.00355	CbGeAlD
Sirolimus—ABCB1—midbrain—endogenous depression	0.00298	0.00351	CbGeAlD
Sirolimus—FGF2—Mecp2 and Associated Rett Syndrome—BDNF—endogenous depression	0.00297	0.0222	CbGpPWpGaD
Sirolimus—ABCB1—thyroid gland—endogenous depression	0.00291	0.00343	CbGeAlD
Sirolimus—ABCB1—endocrine gland—endogenous depression	0.00262	0.00308	CbGeAlD
Sirolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1C—endogenous depression	0.0025	0.0186	CbGpPWpGaD
Sirolimus—ABCB1—nervous system—endogenous depression	0.00245	0.00288	CbGeAlD
Sirolimus—ABCB1—central nervous system—endogenous depression	0.00236	0.00277	CbGeAlD
Sirolimus—FGF2—Regulation of Actin Cytoskeleton—WASF2—endogenous depression	0.00232	0.0173	CbGpPWpGaD
Sirolimus—ABCB1—cerebellum—endogenous depression	0.00231	0.00271	CbGeAlD
Sirolimus—MTOR—ErbB1 downstream signaling—WASF2—endogenous depression	0.00228	0.017	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF2—endogenous depression	0.00224	0.0168	CbGpPWpGaD
Sirolimus—FGF2—Regulation of Actin Cytoskeleton—WASF1—endogenous depression	0.00222	0.0166	CbGpPWpGaD
Sirolimus—EIF4E—BDNF signaling pathway—BDNF—endogenous depression	0.00222	0.0166	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—WASF1—endogenous depression	0.00215	0.0161	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—WASF2—endogenous depression	0.00212	0.0158	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—WASF1—endogenous depression	0.00203	0.0152	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP16—endogenous depression	0.00203	0.0152	CbGpPWpGaD
Sirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.002	0.015	CbGpPWpGaD
Sirolimus—CYP3A7—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00198	0.0148	CbGpPWpGaD
Sirolimus—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.00194	0.0145	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—BDNF—endogenous depression	0.00191	0.0143	CbGpPWpGaD
Sirolimus—ABCB1—brain—endogenous depression	0.00187	0.0022	CbGeAlD
Sirolimus—MTOR—IL4-mediated signaling events—IL10—endogenous depression	0.00171	0.0128	CbGpPWpGaD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00162	0.0121	CbGpPWpGaD
Sirolimus—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.00162	0.0121	CbGpPWpGaD
Sirolimus—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00156	0.0117	CbGpPWpGaD
Sirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00145	0.0108	CbGpPWpGaD
Sirolimus—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00143	0.0107	CbGpPWpGaD
Sirolimus—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.00138	0.0103	CbGpPWpGaD
Sirolimus—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.00134	0.00999	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.0013	0.00971	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.0013	0.0097	CbGpPWpGaD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00122	0.00913	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00117	0.00877	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—ANK3—endogenous depression	0.00112	0.0084	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000984	0.00735	CbGpPWpGaD
Sirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000982	0.00733	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—BDNF—endogenous depression	0.000915	0.00684	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000884	0.0066	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—CYP2D6—endogenous depression	0.000863	0.00645	CbGpPWpGaD
Sirolimus—CYP3A7—Metapathway biotransformation—CYP2D6—endogenous depression	0.000851	0.00636	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—WASF2—endogenous depression	0.000823	0.00615	CbGpPWpGaD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000796	0.00595	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—CACNB2—endogenous depression	0.000793	0.00592	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—WASF1—endogenous depression	0.000789	0.00589	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—WASF2—endogenous depression	0.000785	0.00587	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—WASF1—endogenous depression	0.000753	0.00562	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—CACNA1C—endogenous depression	0.000725	0.00541	CbGpPWpGaD
Sirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00071	0.0053	CbGpPWpGaD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000674	0.00503	CbGpPWpGaD
Sirolimus—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000665	0.00496	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—COMT—endogenous depression	0.000654	0.00489	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—MAOA—endogenous depression	0.000649	0.00485	CbGpPWpGaD
Sirolimus—CYP3A7—Metapathway biotransformation—COMT—endogenous depression	0.000645	0.00482	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.000624	0.00466	CbGpPWpGaD
Sirolimus—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.000615	0.0046	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000608	0.00454	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—WASF2—endogenous depression	0.000583	0.00435	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000575	0.0043	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—WASF1—endogenous depression	0.000559	0.00417	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000546	0.00408	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—WASF2—endogenous depression	0.000532	0.00397	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—WASF1—endogenous depression	0.00051	0.00381	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ADM—endogenous depression	0.000487	0.00363	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—COMT—endogenous depression	0.000473	0.00353	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.000469	0.00351	CbGpPWpGaD
Sirolimus—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.000466	0.00348	CbGpPWpGaD
Sirolimus—FGF2—Immune System—WASF2—endogenous depression	0.000457	0.00342	CbGpPWpGaD
Sirolimus—FGF2—Immune System—WASF1—endogenous depression	0.000439	0.00328	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—POMC—endogenous depression	0.000431	0.00322	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—POMC—endogenous depression	0.000423	0.00316	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000411	0.00307	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CRH—endogenous depression	0.000408	0.00305	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—OXT—endogenous depression	0.000408	0.00305	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR1A—endogenous depression	0.000392	0.00293	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—WASF2—endogenous depression	0.00039	0.00291	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR2C—endogenous depression	0.000379	0.00283	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—WASF1—endogenous depression	0.000374	0.00279	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—NR3C1—endogenous depression	0.000374	0.00279	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ADM—endogenous depression	0.000357	0.00267	CbGpPWpGaD
Sirolimus—MTOR—Immune System—WASF2—endogenous depression	0.000339	0.00254	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR7—endogenous depression	0.000332	0.00248	CbGpPWpGaD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00033	0.00246	CbGpPWpGaD
Sirolimus—MTOR—Immune System—WASF1—endogenous depression	0.000325	0.00243	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000314	0.00235	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—POMC—endogenous depression	0.000306	0.00228	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—OXT—endogenous depression	0.000299	0.00223	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CRH—endogenous depression	0.000299	0.00223	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—WASF2—endogenous depression	0.000296	0.00221	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.00029	0.00217	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR1A—endogenous depression	0.000288	0.00215	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000286	0.00214	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—WASF1—endogenous depression	0.000284	0.00212	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR2C—endogenous depression	0.000278	0.00208	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ADM—endogenous depression	0.00027	0.00202	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000268	0.002	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—TPH1—endogenous depression	0.000265	0.00198	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—TPH1—endogenous depression	0.000244	0.00182	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR7—endogenous depression	0.000244	0.00182	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—HTR2A—endogenous depression	0.000233	0.00174	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CRH—endogenous depression	0.000227	0.00169	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—OXT—endogenous depression	0.000227	0.00169	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—COMT—endogenous depression	0.00022	0.00164	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—WASF2—endogenous depression	0.000219	0.00164	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—MAOA—endogenous depression	0.000218	0.00163	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR1A—endogenous depression	0.000218	0.00163	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	0.000217	0.00162	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR2C—endogenous depression	0.000211	0.00157	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—WASF1—endogenous depression	0.00021	0.00157	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—TPH2—endogenous depression	0.000201	0.0015	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CACNB2—endogenous depression	0.000201	0.0015	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ADM—endogenous depression	0.000201	0.0015	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—DPYD—endogenous depression	0.000198	0.00148	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—POMC—endogenous depression	0.000186	0.00139	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—TPH2—endogenous depression	0.000185	0.00138	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CACNB2—endogenous depression	0.000185	0.00138	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR7—endogenous depression	0.000185	0.00138	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CACNA1C—endogenous depression	0.000184	0.00137	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—DPYD—endogenous depression	0.000182	0.00136	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000177	0.00132	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—TPH1—endogenous depression	0.000176	0.00132	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—HTR2A—endogenous depression	0.000171	0.00127	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CACNA1C—endogenous depression	0.000169	0.00126	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CRH—endogenous depression	0.000168	0.00126	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—OXT—endogenous depression	0.000168	0.00126	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR1A—endogenous depression	0.000162	0.00121	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—CYP2D6—endogenous depression	0.000161	0.0012	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR2C—endogenous depression	0.000156	0.00117	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—CYP2D6—endogenous depression	0.000148	0.0011	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—POMC—endogenous depression	0.000142	0.00106	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR7—endogenous depression	0.000137	0.00102	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—POMC—endogenous depression	0.000136	0.00102	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CACNB2—endogenous depression	0.000133	0.000997	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—TPH2—endogenous depression	0.000133	0.000997	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TPH1—endogenous depression	0.000133	0.000993	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—DPYD—endogenous depression	0.000131	0.000981	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—HTR2A—endogenous depression	0.000129	0.000966	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CACNA1C—endogenous depression	0.000122	0.000912	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—COMT—endogenous depression	0.000122	0.00091	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—MAOA—endogenous depression	0.000121	0.000904	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—COMT—endogenous depression	0.000112	0.000836	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—MAOA—endogenous depression	0.000111	0.00083	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—CYP2D6—endogenous depression	0.000107	0.000797	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—POMC—endogenous depression	0.000103	0.000771	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TPH2—endogenous depression	0.000101	0.000752	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CACNB2—endogenous depression	0.000101	0.000752	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—DPYD—endogenous depression	9.91e-05	0.00074	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—HTR2A—endogenous depression	9.59e-05	0.000717	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CACNA1C—endogenous depression	9.21e-05	0.000688	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TPH1—endogenous depression	8.19e-05	0.000612	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—COMT—endogenous depression	8.09e-05	0.000604	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—CYP2D6—endogenous depression	8.05e-05	0.000601	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—MAOA—endogenous depression	8.03e-05	0.0006	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—POMC—endogenous depression	7.88e-05	0.000589	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—POMC—endogenous depression	7.66e-05	0.000572	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—POMC—endogenous depression	7.23e-05	0.00054	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TPH2—endogenous depression	6.2e-05	0.000463	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CACNB2—endogenous depression	6.2e-05	0.000463	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—DPYD—endogenous depression	6.1e-05	0.000456	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—COMT—endogenous depression	6.1e-05	0.000456	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—MAOA—endogenous depression	6.06e-05	0.000453	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CACNA1C—endogenous depression	5.67e-05	0.000424	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—POMC—endogenous depression	5.23e-05	0.00039	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—CYP2D6—endogenous depression	4.96e-05	0.00037	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—POMC—endogenous depression	3.94e-05	0.000295	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—COMT—endogenous depression	3.76e-05	0.000281	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—MAOA—endogenous depression	3.73e-05	0.000279	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—POMC—endogenous depression	2.43e-05	0.000182	CbGpPWpGaD
